Methylenedioxyallylamphetamine
In-game article clicks load inline without leaving the challenge.
Methylenedioxyallylamphetamine (MDAL or 3,4-methylenedioxy-N-allylamphetamine) is a lesser-known drug. It is the N-allyl derivative of 3,4-methylenedioxyamphetamine (MDA).
Use and effects
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDAL's minimum dose as 180 mg orally and its duration as unknown. MDAL produces few to no effects on its own, but may enhance the effects of psychedelic drugs like LSD.
Chemistry
Synthesis
The chemical synthesis of MDAL has been described.
Society and culture
Legal status
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.